Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture

NCT07640425 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Dupuytren Contracture
Dupuytren Disease of Finger

Interventions

DRUG: [Step1] CNT201 First-dose
DRUG: [Step1] CNT201 Low-dose
DRUG: [Step1] CNT201 Intermediate-dose
DRUG: [Step1] CNT201 High-dose
DRUG: [Step2] CNT201
DRUG: [Step2] Placebo

Sponsor

CONNEXT